carbapenems has been researched along with inosinic acid in 6 studies
| Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (inosinic acid) | Trials (inosinic acid) | Recent Studies (post-2010) (inosinic acid) |
|---|---|---|---|---|---|
| 7,355 | 147 | 5,277 | 1,086 | 29 | 204 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kirikae, T; Miyoshi-Akiyama, T; Narahara, K; Ohmagari, N; Shimojima, M; Tada, T; Tanaka, M; Tojo, M | 1 |
| Hagiya, H; Ogawa, H; Otsuka, F; Takahashi, Y; Yamamoto, A | 1 |
| Abdeltwab, NM; El-Domany, RA; El-Magd, MA; Emara, M; Moustafa, WH | 1 |
| An, J; Guo, L; Lai, K; Ma, Y; Yang, J; Ye, L | 1 |
| Akamatsu, N; Hasegawa, H; Kaku, N; Kawamoto, Y; Kosai, K; Matsuda, J; Morinaga, Y; Uno, N; Yamakawa, H; Yanagihara, K | 1 |
| Akeda, Y; Asada, R; Hagiya, H; Kawahara, R; Nishi, I; Shanmugakani, RK; Tomono, K; Ueda, A; Yamamoto, N; Yoshida, H | 1 |
6 other study(ies) available for carbapenems and inosinic acid
| Article | Year |
|---|---|
Dissemination in Japan of multidrug-resistant Pseudomonas aeruginosa isolates producing IMP-type metallo-β-lactamases and AAC(6')-Iae/AAC(6')-Ib.
Topics: Acetyltransferases; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Inosine Monophosphate; Japan; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 2014 |
Klebsiella oxytoca-producing IMP-1 Detected as the First Strain of Carbapenem-resistant Enterobacteriaceae in Our Hospital.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Hospitals; Humans; Inosine Monophosphate; Klebsiella Infections; Klebsiella oxytoca; Microbial Sensitivity Tests; Middle Aged | 2015 |
Emergence of Imipenem-Resistant Pseudomonas aeruginosa Clinical Isolates from Egypt Coharboring VIM and IMP Carbapenemases.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Egypt; Humans; Imipenem; Inosine Monophosphate; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 2017 |
Molecular characterization of clinical IMP-producing Klebsiella pneumoniae isolates from a Chinese Tertiary Hospital.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Inosine Monophosphate; Klebsiella Infections; Klebsiella pneumoniae; Plasmids; Tertiary Care Centers | 2017 |
Performance evaluation of BD Phoenix™, an automated microbiology system, for the screening of IMP-producing Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Automation, Laboratory; Bacterial Proteins; Carbapenems; DNA, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Imipenem; Inosine Monophosphate; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests | 2018 |
Risk factors for fecal carriage of IMP-6-producing Enterobacteriaceae at a long-term care hospital in Japan: A follow-up report from the northern Osaka multicentre study group.
Topics: Aged, 80 and over; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carrier State; Cross Infection; Enterobacteriaceae Infections; Feces; Female; Follow-Up Studies; Hospitals; Humans; Inosine Monophosphate; Japan; Long-Term Care; Male; Prevalence; Risk Factors | 2018 |